Agios Pharmaceuticals, Inc.
AGIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$103 | -$112 | -$89 | -$97 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $15 | $11 | $11 |
| Change in WC | -$0 | $8 | -$37 | -$46 |
| Other Non-Cash | $2 | $11 | $2 | -$3 |
| Operating Cash Flow | -$88 | -$77 | -$111 | -$133 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$175 | -$131 | -$175 | -$198 |
| Inv. Sales/Matur. | $272 | $221 | $288 | $150 |
| Other Inv. Act. | $0 | -$10 | $0 | $0 |
| Investing Cash Flow | $96 | $79 | $113 | -$49 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4 | $0 | $2 | $5 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $4 | $0 | $2 | $5 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $12 | $2 | $3 | -$177 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81 | $79 | $76 | $254 |
| End Cash | $93 | $81 | $79 | $76 |
| Free Cash Flow | -$90 | -$78 | -$112 | -$134 |